Coronavirus Live Updates: Serum Institute Gets Nod To Make Sputnik Vaccine

0

Coronavirus Live Updates: India has recorded over 2.85 crore Covid cases so far, according to government data.

Coronavirus Live Updates: Serum Institute Gets Nod To Make Sputnik Vaccine

Covid-19 Cases in India: The positivity rate in India has been below 10% for 11 days running. (File)



New Delhi:

Adar Poonawalla’s Serum Institute of India has got permission from the country’s drugs regulator to make Sputnik V, the Russian COVID-19 vaccine. Mr Poonawalla’s company will test, analyse and then manufacture the vaccine at its Pune plant, sources have said. The test licence granted to the Serum Institute means it can develop and manufacture the product for testing, but not sell it. The first dose of Sputnik V was administered in Hyderabad on May 14 as part of a soft launch by Dr Reddy’s Laboratories.

India has recorded over 2.85 crore Covid cases so far, according to government data.

Meanwhile, a government study has found that the coronavirus variant first found in India, the Delta strain, is highly infectious and fast-spreading and drove the savage second surge of COVID-19 in the country. The Delta variant – or the B.1.617.2 strain – ┬áis “more infectious” than the Alpha variant first detected in Kent, UK, says the study by scientists of the Indian SARS COV2 Genomic Consortia and the National Centre for Disease Control.

The Delta variant has also become the dominant variant of concern in the UK and may come with an increased risk of hospitalisation, health officials in Britain have warned. According to Public Health England, which monitors all COVID variants in the country, Delta variant infections rose by 5,472 in a week to hit a total of 12,431 on Thursday. The latest statistics have led experts to conclude that Delta is now closing in to overtake Alpha – the variant of concern first detected in the Kent region of England.

Here are the Live Updates on India Coronavirus Cases:




















Jun 05, 2021 09:27 (IST)
Thane district adds 592 COVID-19 cases, death count up by 38
With 592 new coronavirus positive cases, the infection count in Thane district of Maharashtra

mounted to 5,20,332, an official said on Saturday. These cases were reported on Friday, he said.
As the virus claimed the lives of 38 persons during the day, the death count in the district rose to 9,408. Thane’s COVID-19 mortality rate is 1.80 per cent now, he added.
In neighboring Palghar district, the infection count has now reached 1,11,323, while the death count is 2,145, another official said.
PTI












Jun 05, 2021 09:16 (IST)
PM Reviews Covid Vaccination Drive, Says Wastage Numbers Still High
Prime Minister Narendra Modi today said that the wastage figures of Covid vaccines continue to be on the higher side and asked authorities to take steps to tackle this issue.










Jun 05, 2021 08:23 (IST)
Cases Of Serious Post-Covid Complications Rise In Delhi

The war against the coronavirus is not over for many in Delhi even after they defeated the deadly disease in initial battles. According to doctors, the number of patients with serious post-Covid complications in the outpatient departments (OPD) of the national capital’s hospitals is increasing alarmingly.
Doctors are now handling 25-30 patients with post-Covid complications in the OPDs daily, and the symptoms are far more serious than those reported in the first wave. Patients are requiring oxygen support several weeks after recovering from the infection; last year, the most common symptom was fatigue.
Read more here












Jun 05, 2021 08:08 (IST)
Pfizer Vaccine: For Delta Variant, Need Shorter Gap Between Vaccine Doses: Lancet Study
The Pfizer vaccine is far less effective against the Delta variant of Covid, which is dominant in India, compared to the original strain of the coronavirus, says The Lancet journal in a new study.












Jun 05, 2021 07:11 (IST)
US Lawmakers Ask US President Joe Biden For Equitable Administration Of Covid-19 Vaccines Across The World
Over 40 American lawmakers on Friday wrote to US President Joe Biden, urging him to take all the necessary measures to ensure equitable administration of COVID-19 vaccines across the world.










Jun 05, 2021 06:42 (IST)
US Contributed $2 Billion To Global Alliance On Vaccines Gavi For Covax Facility

US has so far contributed $2 billion to GAVI for COVAX facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines. The information about the contribution was shared by Jeremy Konyndyk, Executive Director of the USAID COVID-19 Task Force on Friday in a special briefing of US Department of State.
“We have given, so far, $2 billion to GAVI for the COVAX Initiative, the COVAX platform, which is facilitating equitable distribution of vaccines around the world,” said Mr Konyndyk.










Jun 05, 2021 06:05 (IST)










Jun 05, 2021 05:57 (IST)
US sending $266.5 million in aid to Afghanistan for Covid response

The United States announced more than $266 million in additional humanitarian aid for Afghanistan, intended mainly for its Covid-19 response, as foreign troops continue their withdrawal from the country.
“As the United States withdraws military forces from Afghanistan, our enduring commitment is clear,” top US diplomat Antony Blinken said. “We remain engaged through our full diplomatic, economic and assistance toolkit to support the peaceful, stable future the Afghan people want and deserve.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here

All the data shown above will be stored by www.rajpostexam.com on https://www.rajpostexam.com/. At any point of time, you can contact us and select the data you wish to anonymise or delete so it cannot be linked to your email address any longer. When your data is anonymised or deleted, you will receive an email confirmation. We also use cookies and/or similar technologies to analyse customer behaviour, administer the website, track users' movements, and to collect information about users. This is done in order to personalise and enhance your experience with us. Click here to read our Cookie Policy.